Entera Bio Ltd. Warrant
ENTXW
ENTXW was delisted on the 27th of June, 2023.
1 hedge funds and large institutions have $37 invested in Entera Bio Ltd. Warrant in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$62 |
Top Sellers
ENTXW Hedge Fund Activity: Q4 2022 in Review
1 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Entera Bio Ltd. Warrant (ENTXW) for Q4 2022, worth a combined $37.
Fund positioning in ENTXW was balanced in Q4 2022: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $62.
- 1 institutional investor held Entera Bio Ltd. Warrant (ENTXW) as of Q4 2022, unchanged from Q3 2022.
- Funds reported $37 of Entera Bio Ltd. Warrant stock for Q4 2022.
- 1 fund opened new Entera Bio Ltd. Warrant positions in Q4 2022 and 1 closed out, a net change of 0 holders.
- The largest Entera Bio Ltd. Warrant buyer in Q4 2022 was UBS Group, an estimated $62 added.
Based on aggregated 13F filings for Q4 2022.